Moreover, considering the negative impact of the MEK/ERK signaling pathway on Bmf, the use of MEK inhibitors could enhance the efficacy of cancer therapy in some cases; meanwhile, dysregulation of Bmf might be linked with the development of resistance to MEK inhibitors. The gene discussed is BMF; the disease is cancer.